Chart of the Day: Hiding Out in Healthcare Has Been Profitable
Investors wanting less exposure to beta and risk are seeing value in the XLV.
Microsoft Price Target After $25 Billion Bond Sale Update
The Big Tech firm enjoyed a strong earnings beat.
Merck Beats Estimates and Appeals as a Long-Term Investment
The pharma giant continues to see results from a powerhouse.
Trimming This Small-Cap Biotech on Strength as We Eye the Chart
Here’s what we’re seeing technically ahead of next week’s earnings.
Alphabet Miss, Why Fed Shouldn’t Raise Rates, All Eyes on Amazon
Higher statistical growth coupled with accelerating statistical inflation seems like a good reason to raise rates. I’ll explain why it’s not.
We’re No Longer Oversold, but Was the Buying Real or Just Short Covering?
Stocks are up over the last three days. But it’s earnings season and we don’t yet know if the buying will continue.
Chart of the Day: Is This the Right Spot for Applied Materials?
Failure to break lower means the next move may be up.
Micron Price Target After Key Competition Posts Big Revenue Beat
SK Hynix appears to be boosting the larger memory stock group.
A Cloudy Forecast? Grading the Neocloud Stocks
Are there opportunities in the neocloud sub-sector? Let’s look at three of the best-known names.
Old-Timers Called It Glass Works. What Call Should Today’s Traders Make?
A very good quarter and guidance, but bearish signaling has me calling it this way.